Old Web
English
Sign In
Acemap
>
authorDetail
>
Takashi Nomiyama
Takashi Nomiyama
International University of Health and Welfare
Endocrinology
Internal medicine
Diabetes mellitus
Medicine
Sitagliptin
4
Papers
14
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet
2020
Heliyon
Tsuyoshi Horikawa
Takako Kawanami
Yuriko Hamaguchi
Yuki Tanaka
Shotaro Kita
Ryutaro Ryorin
Yuichi Takashi
Hiroyuki Takahashi
Makito Tanabe
Toshihiko Yanase
Daiji Kawanami
Takashi Nomiyama
Show All
Source
Cite
Save
Citations (3)
Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases
2020
Journal of Atherosclerosis and Thrombosis
Takashi Nomiyama
Show All
Source
Cite
Save
Citations (0)
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
2020
Cardiovascular Diabetology
Masato Furuhashi
Ichiro Sakuma
Takeshi Morimoto
Yukimura Higashiura
Akiko Sakai
Megumi Matsumoto
Mio Sakuma
Michio Shimabukuro
Takashi Nomiyama
Osamu Arasaki
Koichi Node
Shinichiro Ueda
Show All
Source
Cite
Save
Citations (10)
1